• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
  • 0Shopping Cart
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

ProtectOurCare 1024px

ACA Update | July 21, 2017: Despite Public Opposition, ACA Repeal Still Alive; Vote Planned Early Next Week

July 21, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Financial Toxicity, Health Care Coverage, Health Equity, Pre-Existing Conditions NCCS News /by actualize

AHCA

Prior to the Affordable Care Act (ACA), cancer survivors were at the mercy of the health care system, often forced to pay exorbitant premiums or simply denied coverage altogether. Today, America’s 16 million cancer survivors benefit from the ACA’s patient protections that are critical to providing them with quality, affordable, and accessible health care coverage. NCCS is actively engaged in advocating to ensure this unprecedented access for cancer patients and providers continues.
Since January, the health care debate has been tumultuous and unpredictable—and this week was no exception. Four Republican senators announced early in the week that they oppose the Better Care Reconciliation Act (BCRA), stopping the bill from moving forward as planned.

Thanks to your advocacy efforts here in D.C., the phone calls, emails and letters to your Members of Congress, YOU helped stop this destructive legislation from becoming law last week, as Republican leader Mitch McConnell had planned. But there is no time to celebrate, as McConnell is intent on going against public opinion and repealing the Affordable Care Act (ACA).

Here’s what happened this week:

The Congressional Budget Office (CBO) reported that the revised BCRA would result in 22 million more American uninsured. The report does not include an analysis of the Cruz amendment that would let insurers sell “skinny plans” that don’t meet Obamacare insurance regulations, as long as they also sell ACA-compliant ones. Premiums on the individual market under this version are expected to increase by significantly in coming years. The Cruz amendment would destabilize the insurance market and leave even more people uninsured.

As The Hill reported, Senators are hurtling toward an Obamacare repeal vote early next week, even though they currently lack the votes for either option on the table. Senators are unclear what they will be voting on next week, with just days to go before a critical vote to begin debate that’s expected to come on Tuesday. The two leading options are a repeal-only bill or an updated version of the Senate’s repeal-and-replacement measure.

The CBO has estimated that 32 million people would lose coverage under the repeal and delay bill. This is the same bill that the Senate passed in 2015 but was vetoed by President Obama. CBO updated its estimates of the 2015 bill earlier this year. The repeal/delay bill eliminates the Medicaid expansion, but does not have the same deep cuts to the Medicaid program as the AHCA and BCRA. It retains patient protections for people with pre-existing conditions, but eliminates subsidies and cost-sharing reductions to help people afford insurance, which would lead to significant premium increases (20-25% in the first year, up to 100% by 2026) and coverage losses.

The coverage losses alone would be devastating for cancer patients and survivors. We oppose ACA “repeal and delay,” as 32 million Americans would lose coverage and premiums would rise, making insurance unaffordable for cancer patients and survivors.

Please keep calling your Senators and ask they vote NO and work together in a bipartisan manner to improve health insurance. Call today at (844) 257-6227.


Related Posts

https://canceradvocacy.org/blog/wcoe-07-21-2017/

https://canceradvocacy.org/nccs-news/nccs-statement-bcra-developments-senate/


Tags: aca update, affordable care act, cancer care, financial issues, Medicaid, pre-existing conditions, repeal and replace
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/01/ProtectOurCare-1024px.jpg 512 1024 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-07-21 17:11:332017-07-21 17:11:33ACA Update | July 21, 2017: Despite Public Opposition, ACA Repeal Still Alive; Vote Planned Early Next Week
You might also like
NCCS Blog CPM Logo 17 Patient Groups Urge Appeals Court to Uphold Health Care Law
NCCS Starburst 250px What Caught Our Eye: Idaho Allows Insurers to Ignore ACA Rules; Op-ed: Right to Try a ‘Disaster in the Making’; Financial Toxicity; and More
FDA Building NCCS Joins Letter Highlighting Impact of Gov’t Shutdown on FDA’s Work on Behalf of Patients
ThumbInfographic2 Decision-Making in Cancer Care: Communication (INFOGRAPHIC)
NCCS Starburst 250px NCCS Health Care Roundup: Gov’t Shutdown Threat; NCCS Webinar; Analysis of 8 Democratic Universal Health Care Plans; More
NCCS Blog CPM Logo NCCS Statement on District Court Ruling Affordable Care Act Unconstitutional
Elevating Survivorship Logo web FB TW 2020 NCCS Elevate Ambassadors Selected to Improve Survivorship Care in Local Communities
affordable care act NCCS Statement on President Trump’s Harmful Health Care Executive Order

Latest News

HHS Humphrey bldg 1200

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

December 22, 2020
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
NCCS Letter to HHS

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

December 9, 2020
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-09 17:30:502020-12-10 08:22:55NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
HHS Humphrey bldg 1200

NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

December 3, 2020
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-03 21:26:462020-12-03 21:28:06NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

What Caught Our Eye: Health Care Repeal News; John McCain’s Diagnosis... NCCS Starburst 250px ProtectOurCare 1024px ACA Update | July 27, 2017: Senate GOP Tries “Skinny Repeal,” Which...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute